PLYX POLARYX THERAPEUTICS INC revenue, earnings and financials
For the quarter ended June 30, 2026, POLARYX THERAPEUTICS INC reported revenue of n/a, net income of −$1.38M and diluted EPS of −$0.03; for the fiscal year ended December 2025 revenue was n/a.
PLYX annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$7.82M, net income −$8.99M (margin n/a), EPS −$0.20
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$4.35M, net income −$30.4M (margin n/a), EPS −$0.89
PLYX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$1.38M, EPS −$0.03
- Quarter ended Mar 31, 2026: revenue n/a, net income −$2.54M, EPS −$0.05
- Quarter ended Jun 30, 2025: revenue n/a, net income −$1.01M, EPS −$0.02
- Quarter ended Mar 31, 2025: revenue n/a, net income −$5.05M, EPS −$0.11
PLYX cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$3.94M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$2.57M, share buybacks n/a
PLYX balance sheet
- Jun 30, 2026: cash $11.5M, total assets $11.8M, total liabilities $873K, shareholders' equity $10.9M
- Mar 31, 2026: cash $3.08M, total assets $3.50M, total liabilities $1.01M, shareholders' equity $2.49M
- Dec 31, 2025: cash $5.14M, total assets $5.17M, total liabilities $605K, shareholders' equity $4.57M
- Dec 31, 2024: cash $4.62M, total assets $5.00M, total liabilities $289K, shareholders' equity $4.71M
Is PLYX profitable?
No. POLARYX THERAPEUTICS INC lost $8.99M in its latest fiscal year.